At Surgical Innovations Group Plc, we are deeply committed to Environmental, Social, and Governance (ESG), with a focus on sustainable, ethical business practices, underpinned by transparency.

Our ESG strategy is designed to drive an absolute and tangible environmental footprint reduction, positive social impacts, while maintaining robust corporate governance.

Group ESG Strategy Headlines:

• NetZero Scope 1 and 2 by 2030: We are committed to achieving NetZero emissions for Scope 1 and 2 by 2030, aligning with global efforts to mitigate climate change and reduce greenhouse gas emissions.
• Net Zero Scope 3 by 2040: Our commitment extends to achieving Net Zero emissions for Scope 3 by 2040, encompassing our entire value chain and ensuring comprehensive environmental responsibility.
• Year-over-Year Environmental Footprint Reduction: Since 2022 we have and continue to reduce our Group’s environmental footprint year-over-year through sustained investment in our Net Zero strategy and will continue to do so across the strategy period to 2030.
• Absolute Energy Consumption Reduction: Between 2022 and 2023, we successfully reduced our energy consumption by 12.1%, displaying our effective implementation of energy-saving initiatives.
• 2024 Investments and Energy Optimisation: In 2024, we have already invested £14,000 in projects aimed at optimising and reducing our energy consumption by an additional 14%, demonstrating our proactive approach to energy efficiency.
• Transition to Hybrid and Electric Vehicle Fleet by 2026: A pivotal component of our carbon footprint reduction strategy is the transition of our entire business vehicle fleet to hybrid or electric by the end of 2026.

Our ESG governance strategy is a core part of our corporate identity, guiding our actions and decisions towards a sustainable and responsible future. Through these initiatives, Surgical Innovations Group Plc aims to lead by example within our peer group in the pursuit of a greener, more equitable world.